Tool Room 3rd shift
PCI Pharma Services | |
United States, Pennsylvania, Philadelphia | |
3001 Red Lion Road (Show on map) | |
Mar 06, 2026 | |
|
Life changing therapies. Global impact. Bridge to thousands of biopharma companies and their patients. We are PCI. Our investment is in People who make an impact, drive progress and create a better tomorrow. Our strategy includes building teams across our global network to pioneer and shape the future of PCI. Position Title: Toolroom Attendant Reports to: Shift Supervision FLSA Status: Ful-Time Hourly Location: Philadelphia, PA ESSENTIAL FUNCTIONS: The essential functions of this position include but are not limited to: Responsible for the efficient completion of assign tasks within the scope of the position. Provides effective equipment and material support necessary to achieve PCI's business objectives. Provides support to both operations and technical staff in a professional and respectful manner which facilitates a positive working environment. Responsibilities
EDUCATION OR EQUIVALENT: High School Diploma or equivalent education. Technical or Vocational Training preferred. KNOWLEDGE/SKILLS REQUIREMENTS:
POSITION PHYSICAL REQUIREMENTS: Ability to lift 60 lbs on a frequent and routine basis. Ability to stand for long periods of time. Ability to use ladder/stairwell to 12 ft. Join us and be part of building the bridge between life changing therapies and patients. Let's talk future Equal Employment Opportunity (EEO) Statement: At PCI, Equity and Inclusion are at the core of our company's purpose: Together, delivering life-changing therapies. We are committed to cultivating an inclusive workplace by holding ourselves accountable to the highest standards of understanding, fairness, respect, and equal opportunity - at every level. We envision a PCI community where everyone can belong and grow, and we strive to bring this vision to reality by continuously and intentionally assessing our people practices, policies and programs, marketing approach, and workplace culture. | |
Mar 06, 2026